← 產業報告目錄
Periodontal Therapeutics Market Size, Share & Trends Analysis Report, By Disease (Chronic Periodontal Disease, Aggressive Periodontal Disease, Gingivitis), By Drug Type (Doxycycline, Minocycline, Chlorhexidine, Metronidazole)), By Distribution Channel, By Region, Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-28頁數 175報告編號 INSIGHTACE-6d1e766c23
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Periodontal Therapeutics Market stood at USD 843.6 Mn in 2023, and is expected to reach USD 1,497.4 Mn by 2031, recording a CAGR of 7.6% from 2024 through 2031.
At its core, Periodontal Therapeutics pertains to landscape are risingly turning to these solutions to meet contemporary demands.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Periodontal Therapeutics Market Snapshot
Chapter 4. Global Periodontal Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: Disease Outlook Estimates & Trend Analysis
5.1. Disease Outlook & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Disease Outlook:
5.2.1. Gingivitis
5.2.2. Chronic Periodontal Disease
5.2.3. Aggressive Periodontal Disease
5.2.4. Others
Chapter 6. Market Segmentation 2: Drug Type Outlook Estimates & Trend Analysis
6.1. Drug Type Outlook & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Drug Type Outlook:
6.2.1. Doxycycline
6.2.2. Minocycline
6.2.3. Chlorhexidine
6.2.4. Metronidazole
6.2.5. Other drug types
Chapter 7. Market Segmentation 3: Distribution Channel Outlook Estimates & Trend Analysis
7.1. Distribution Channel Outlook & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Distribution Channel Outlook:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Channel
Chapter 8. Periodontal Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.1.2. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.1.3. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.1.4. North America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.2.2. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.2.3. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.2.4. Europe Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.3.2. Asia Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.3.3. Asia-Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.3.4. Asia Pacific Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.4.2. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.4.3. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.4.4. Latin America Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Disease Outlook, 2024-2031
8.5.2. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Drug Type Outlook, 2024-2031
8.5.3. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts Distribution Channel Outlook, 2024-2031
8.5.4. Middle East & Africa Periodontal Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Pfizer Inc.
9.2.2. Lupin Ltd
9.2.3. Teva Pharmaceuticals USA, Inc.
9.2.4. Sun Pharmaceutical Industries Ltd.
9.2.5. Tokyo Chemical Industry Co., Ltd.
9.2.6. Bausch Health Companies Inc.
9.2.7. USAntibiotics
9.2.8. Melinta Therapeutics LLC
9.2.9. Cipla, Inc.
9.2.10. Chartwell Pharmaceuticals LLC.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們